David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Alcoa
AA
$13.7B
| $102M | 0.16% |
2,194,837
+735,964
| +50% | +$29.4M |
|
152
EOG Resources
EOG
$80.3B
| $102M | 0.16% |
1,056,999
-149,302
| -12% | -$13.5M |
|
153
PUT
SLB Ltd
SLB
$79.9B
| $102M | 0.16% |
1,460,200
+626,800
| +75% | +$41.4M |
|
154
Constellation Brands
STZ
$23.2B
| $101M | 0.16% |
505,746
+283,247
| +127% | +$56.1M |
|
155
Synopsys
SNPS
$76.2B
| $101M | 0.15% |
1,248,813
+119,448
| +11% | +$9.27M |
|
156
PUT
Verizon
VZ
$205B
| $100M | 0.15% |
2,027,200
+291,300
| +17% | +$13.7M |
|
157
Southwest Airlines
LUV
$19.8B
| $99.5M | 0.15% |
1,777,493
+1,396,908
| +367% | +$78.4M |
|
158
AbbVie
ABBV
$468B
| $99.1M | 0.15% |
1,115,673
-1,981,774
| -64% | -$151M |
|
159
PUT
Goldman Sachs
GS
$303B
| $98M | 0.15% |
413,300
+74,400
| +22% | +$16.8M |
|
160
American International
AIG
$39.8B
| $97.7M | 0.15% |
1,591,049
+440,974
| +38% | +$27.5M |
|
161
Trimble
TRMB
$14B
| $97.6M | 0.15% |
2,486,370
-38,281
| -2% | -$1.46M |
|
162
Kinder Morgan
KMI
$69B
| $97.4M | 0.15% |
5,075,856
-499,999
| -9% | -$9.74M |
|
|
BIVV
163
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $97.1M | 0.15% |
1,700,839
+201,557
| +13% | +$11.8M |
|
164
Broadcom
AVGO
$1.75T
| $96.7M | 0.15% |
3,984,910
+3,780,380
| +1,848% | +$93.5M |
|
165
Progressive
PGR
$127B
| $94.6M | 0.15% |
1,953,992
-1,286,250
| -40% | -$60.2M |
|
|
KSU
166
DELISTED
Kansas City Southern
KSU
| $93.8M | 0.14% |
863,497
-102,108
| -11% | -$10.7M |
|
167
TechnipFMC
FTI
$30.4B
| $93.2M | 0.14% |
4,486,964
-708,330
| -14% | -$14.2M |
|
|
HOLX
168
DELISTED
Hologic
HOLX
| $92.7M | 0.14% |
2,526,210
+1,705,585
| +208% | +$68.8M |
|
|
EVHC
169
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $92M | 0.14% |
2,045,624
+217,959
| +12% | +$11.6M |
|
170
Fidelity National Financial
FNF
$12.7B
| $91.2M | 0.14% |
2,766,736
+548,069
| +25% | +$17.9M |
|
171
Aptiv
APTV
$10B
| $91M | 0.14% |
924,494
+326,149
| +55% | +$30.8M |
|
172
DXC Technology
DXC
$1.73B
| $90.7M | 0.14% |
1,221,457
-392,588
| -24% | -$27.9M |
|
173
Tractor Supply
TSCO
$18.2B
| $90.6M | 0.14% |
7,161,405
-3,172,140
| -31% | -$36M |
|
174
Devon Energy
DVN
$54B
| $90.6M | 0.14% |
2,467,984
-564,377
| -19% | -$18.3M |
|
|
GRA
175
DELISTED
W.R. Grace & Co.
GRA
| $89.1M | 0.14% |
1,235,513
-231,217
| -16% | -$16.3M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.